Trial Profile
A Phase I Dose Escalation Study on the Tolerability and Activity of TriN 2755 in Patients With Advanced Solid Tumors and Sarcomas Using Two Different Dosage Regimens
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs TRIN 2755 (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors TRIN Pharma
- 17 Dec 2010 New trial record